OmniAb, Inc. Q3 2026 Earnings Call Summary
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- OABI OmniAb
Named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR-0.3% 30d
Industrial Select Sector SPDR holds the industrials sector that OmniAb belongs to, so it often moves with news about it.
- IQV IQVIA Holdings-3.9% 11d
IQVIA Holdings is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.
- INCY Incyte
Incyte is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.
- MEDP Medpace Holdings+7.4% 11d
Medpace Holdings is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.
- CRL Charles River Laboratories International+10.4% 13d
Charles River Laboratories International is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.
- ICLR ICON Public-5.4% 14d
ICON Public is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| OABI | -9.70% | +3.62% | base | -0.39% | +0.98% | after close | after close |
| XLI | -0.27% | +0.65% | base | +1.38% | +2.35% | after close | after close |
| IQV | +2.48% | +4.33% | base | -3.33% | -1.83% | after close | after close |
| INCY | -5.93% | -2.95% | base | -0.32% | -2.33% | after close | after close |
| MEDP | +3.82% | +6.25% | base | -0.69% | +1.79% | after close | after close |
| CRL | -0.60% | +4.03% | base | -5.87% | -2.16% | after close | after close |
| ICLR | -13.00% | +1.37% | base | -2.85% | -3.55% | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
OmniAb, Inc. Q3 2026 Earnings Call Summary Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| CRL | that day | -5.87% | final price |
| CRL | the next day | -2.16% | final price |
| CRL | three days earlier | +4.03% | final price |
| CRL | five days earlier | -0.60% | final price |
| ICLR | that day | -2.85% | final price |
| ICLR | the next day | -3.55% | final price |
| ICLR | three days earlier | +1.37% | final price |
| ICLR | five days earlier | -13.00% | final price |
| INCY | that day | -0.32% | final price |
| INCY | the next day | -2.33% | final price |
| INCY | three days earlier | -2.95% | final price |
| INCY | five days earlier | -5.93% | final price |
| IQV | that day | -3.33% | final price |
| IQV | the next day | -1.83% | final price |
| IQV | three days earlier | +4.33% | final price |
| IQV | five days earlier | +2.48% | final price |
| MEDP | that day | -0.69% | final price |
| MEDP | the next day | +1.79% | final price |
| MEDP | three days earlier | +6.25% | final price |
| MEDP | five days earlier | +3.82% | final price |
| OABI | that day | -0.39% | final price |
| OABI | the next day | +0.98% | final price |
| OABI | three days earlier | +3.62% | final price |
| OABI | five days earlier | -9.70% | final price |
| XLI | that day | +1.38% | final price |
| XLI | the next day | +2.35% | final price |
| XLI | three days earlier | +0.65% | final price |
| XLI | five days earlier | -0.27% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (jointly held), worth $15,001 - $50,000 on 14 Sep 2026. That is 46 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 8 Sep 2026. That is 52 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 57 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Incyte (INCY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Charles River Laboratories International (CRL) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Icon (ICLR) (jointly held), worth $15,001 - $50,000 on 14 Aug 2026. That is 77 days before publication. Filed 1 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “OmniAb, Inc. Q3 2026 Earnings Call Summary” looks
12 out of 100
“OmniAb, Inc. Q3 2026 Earnings Call Summary” scores 12 out of 100. The score uses 1 sources.